Anziva Pharmaceuticals is on a mission to reformulate trusted pain medicines into non-opioid products designed to work better in the real world.
Our lead program, J'Neura™, is a transdermal patch designed specifically for the knee.

Most pain patches are designed for the whole body. J'Neura is a flexible, waterproof, non-opioid patch designed around how the knee moves, so it stays in place and keeps delivering through a full day of activity.
Pre-clinical. Available for partnering
*In vitro comparative testing versus current prescription brand
Led by a founder who developed 35+ products at Teva Pharmaceuticals, and supported by advisors from across formulation, regulatory, pain medicine and commercialization.

FOUNDER | CEO
Ex-Teva; 35+ products developed across oral, topical, transdermal and injectable forms

ADVISOR | PRODUCT
Serial founder; 20+ FDA-approved complex generics at a prior company

ADVISOR | BUSINESS
Former CEO of three medtech companies, including a licensing, a sale and a merger

ADVISOR | CHRONIC PAIN
Dual board-certified in Pain Management and Neurology, with leadership roles at the University of South Florida and the James A. Haley VA
A focused pipeline in non-opioid pain.

Knee pain patch
Pre-clinical
Lead program

Sustained-release patch
Early concept development in progress

Non-invasive gel
Early concept development in progress

Long-acting formulations
Early concept development in progress





We’re seeking licensing, co-development and commercialization partners, and investors who share our vision for better non-opioid pain therapies.
Licensing, co-development, regional or global commercialization, or strategic acquisition of J’Neura™.
Learn about Anziva’s platform, pipeline and path to value.